Human Liver Model Market Forecast (2026–2030): Expansion Trends
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Human Liver Model Market Be By 2030 Compared To Its 2026 Market Size?
The human liver model market size has expanded considerably in recent years. This market is expected to increase from $2.62 billion in 2025 to $2.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.5%. Historically, this growth can be attributed to factors such as higher drug attrition rates due to liver toxicity, the inherent limitations of traditional animal models, a surge in pharmaceutical research and development activities, the early adoption of 2D liver cell culture models, and an intensified focus on evaluating drug safety.
The human liver model market is poised for rapid expansion over the next few years. It is projected to grow to $5.02 billion by 2030, achieving a compound annual growth rate (CAGR) of 14.0%. This growth during the forecast period can be attributed to factors such as the increasing demand for precision toxicology models, the wider adoption of organ-on-chip technologies, a rising regulatory focus on minimizing animal testing, greater investment in advanced in vitro research tools, and the increased use of human-relevant models in early stages of drug development. Significant trends anticipated for this period include the growing acceptance of advanced in vitro liver models for toxicity testing, the expanding application of liver organoids in drug discovery pipelines, a developing preference for human-relevant models over animal testing, the broadening use of liver-on-a-chip applications in preclinical research, and a heightened demand for predictive hepatotoxicity assessment tools.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report
Which Strong Drivers Are Impacting The Human Liver Model Market Growth?
The anticipated growth of the human liver model market is primarily fueled by the increasing number of clinical trials. These trials are research endeavors conducted to assess the safety and effectiveness of medical interventions, treatments, or drugs in human subjects. Within these studies, human liver models are employed to simulate and investigate drug metabolism and hepatotoxicity, which is crucial for pharmaceutical development. For instance, data from December 2024, provided by the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, indicated a rise in the total number of clinical trials initiated in the UK, moving from 411 in 2022 to 426 in 2023. This upward trend in clinical trials is therefore a significant driver for the human liver model market.
Which Segments Define The Human Liver Model Market Segment Structure?
The human liver model market covered in this report is segmented –
1) By Product: Liver Organoids, Liver-On-A-Chip, 2D Models, 3D Bioprinting
2) By Application: Educational, Drug Discovery, Other Applications
3) By End Users: Research Institutes, Pharmaceutical Companies, Other End Users
Subsegments:
1) By Liver Organoids: Primary Liver Organoids, Induced Pluripotent Stem Cell (iPSC)-Derived Organoids
2) By Liver-On-A-Chip: Microfluidic Liver Chips, Multi-Organ Chip Systems
3) By 2D Models: Liver Cell Cultures, Liver Cell Lines
4) By 3D Bioprinting: Bioprinted Liver Tissues, Hybrid Bioprinted Models
Which Trends Are Contributing To Changes In The Human Liver Model Market?
Major companies in the human liver model market are concentrating on developing advanced systems, such as single-organ higher throughput (HT) systems, to improve the adoption of predictive human liver models and achieve a competitive edge. A single-organ higher throughput (HT) system serves as a technology designed for scalable and cost-effective drug discovery, effectively addressing obstacles in the wider use of predictive human liver models. For instance, in February 2023, CN Bio, a UK-based organ-on-a-chip company, launched its PhysioMimix with Liver-48 plate, a single-organ higher throughput (HT) system specifically engineered to tackle impediments to utilizing predictive human liver models in drug discovery. This technology offers a scalable and cost-effective approach, enabling researchers to conduct larger-scale comparative studies on drug disposition, efficacy, or safety. The Liver-48 plate is a multi-chip consumable that miniaturizes the company’s human liver model for various applications, including predicting drug-induced liver injury and evaluating drug metabolism.
Who Are The Established Players Within The Human Liver Model Market?
Major companies operating in the human liver model market are Corning Incorporated, EISCO Scientific LLC, BioIVT LLC, Cyprotex plc, Emulate Inc., Cellink AB, Nortis Inc., InSphero AG, CN Bio Innovations Ltd., TissUse GmbH, HemoShear Therapeutics Inc., Cyfuse Biomedical, MIMETAS BV, Biopredic International Sarl, ZenBio, Hurel Corporation, Regenovo, Pandorum, Organovo Holdings Inc., BICO Group, Hepregen Corporation, Kirkstall Ltd., HepaLife Technologies Inc., Cellaïon SA.
Get The Full Human Liver Model Market Report:
https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report
Which Geographic Region Dominates The Human Liver Model Market?
North America was the largest region in the human liver model market in 2025. The regions covered in the human liver model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Human Liver Model Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report
Browse Through More Reports Similar to the Global Human Liver Model Market 2026, By The Business Research Company
Liver Diseases Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
Rat Model Market Report 2026
https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report
Anatomical Models Market Report 2026
https://www.thebusinessresearchcompany.com/report/anatomical-models-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
